02380 408 600 Contact us
Menu
×

Publications

  • Publication Subject

  • Filter by Author

Antipsychotics and stroke: the story to date

  • Author

    Layton D Cox A

    Debabrata Roy, Anthony Cox

  • Cite

    The Pharmaceutical Journal. January 2009

View Publication

Prescriber adoption of newly approved selective COX-2 inhibitors.

  • Author

    Deborah Layton Patrick C Souverein Eibert R Heerdink Saad A W Shakir A G C Egberts

    Deborah Layton, Patrick Souverein, Eibert Heerdink, Saad Shakir, Antoine Egberts

  • Cite

    Pharmacoepidemiol Drug Safety. 2008 Dec;17(12):1168-74

View Publication

Adverse drug reactions: Neuropsychiatric drug reactions associated with varenicline (Champix).

  • Author

    Layton D

    Deborah Layton

  • Cite

    The Pharmaceutical Journal. June 2008

View Publication

Developing tools for the safety specification in risk management plans: lessons learned from a pilot project.

  • Author

    Andrew J P Cooper Sally Lettis Charlotte L Chapman Stephen J W Evans Patrick C Waller Saad Shakir Nassrin Payvandi Alison B Murray

    Andrew Cooper, Sally Lettis, Charlotte Chapman, Stephen Evans, Patrick Waller, Saad Shakir, Nassrin Payvandi, Alison Murray

  • Cite

    Pharmacoepidemiol Drug Saf. 2008 May;17(5):445-54

View Publication

Prescription Event Monitoring in the United Kingdom

  • Author

    Shakir SAW

    Saad Shakir

  • Cite

    Pharmacoepidemiology and Therapeutic Risk Management. April 2008

View Publication

European commission consultation on pharmacovigilance

  • Author

    Patrick Waller Keith Beard Toine Egberts Stephen Evans Jesper Hallas Joerg Hasford Joan-Ramon Laporte Nicholas Moore Saad Shakir Miriam Sturkenboom

    Patrick Waller, Keith Beard, Toine Egberts, Stephen Evans, Jesper Hallas, Joerg Hasford, Joan-Ramon Laporte, Nicholas Moore, Saad Shakir, Miriam Sturkenboom

  • Cite

    Pharmacoepidemiol Drug Saf. 2008 Feb;17(2):108-9

View Publication

Monitoring the safety of pioglitazone : results of a prescription-event monitoring study of 12,772 patients in England.

  • Author

    Rachna Kasliwal Lynda V Wilton Saad A W Shakir

    Rachna Kasliwal, Lynda Wilton, Saad Shakir

  • Cite

    Drug Safety. 2008;31(10):839-50

View Publication

Safety profile of esomeprazole : results of a prescription-event monitoring study of 11 595 patients in England.

  • Author

    Miranda Davies Lynda V Wilton Saad A W Shakir

    Miranda Davies, Lynda Wilton, Saad Shakir

  • Cite

    Drug Safety. 2008;31(4):313-23

View Publication

Evaluation of risk profiles for gastrointestinal and cardiovascular adverse effects in nonselective NSAID and COX-2 inhibitor users: a cohort study using pharmacy dispensing data in The Netherlands.

  • Author

    Deborah Layton Patrick C Souverein Eibert R Heerdink Saad A W Shakir Antoine C G Egberts

    Deborah Layton, Patrick Souverein, Eibert Heerdink, Saad Shakir, Antoine Egberts

  • Cite

    Drug Saf. 2008;31(2):143-58

View Publication

Safety of nateglinide as used in general practice in England: results of a prescription-event monitoring study.

  • Author

    B Twaites L V Wilton D Layton S A W Shakir

    Beverley Twaites, Lynda Wilton, Deborah Layton, Saad Shakir

  • Cite

    Acta Diabetol. 2007 Dec;44(4):233-9

View Publication

The safety profiles of orlistat and sibutramine: results of prescription-event monitoring studies in England.

  • Author

    Michael J Perrio Lynda V Wilton Saad A W Shakir

    Michael Perrio, Lynda Wilton, Saad Shakir

  • Cite

    Obesity. 2007 Nov;15(11):2712-22

View Publication

A modified prescription-event monitoring study to assess the introduction of Flixotide Evohaler into general practice in England: an example of pharmacovigilance planning and risk monitoring.

  • Author

    Michael J Perrio Lynda V Wilton Saad A W Shakir

    Michael Perrio, Lynda Wilton, Saad Shakir

  • Cite

    Pharmacoepidemiol Drug Saf. 2007 Sep;16(9):969-78

View Publication

The safety of quetiapine: results of a post-marketing surveillance study on 1728 patients in England.

  • Author

    Beverley R Twaites Lynda V Wilton Saad A W Shakir

    Beverley Twaites, Lynda Wilton, Saad Shakir

  • Cite

    J Psychopharmacol. 2007 Jun;21(4):392-9

View Publication

An analysis of the exclusion criteria used in observational pharmacoepidemiological studies

  • Author

    Michael Perrio Patrick C Waller Saad A W Shakir

    Michael Perrio, Patrick Waller, Saad Shakir

  • Cite

    Pharmacoepidemiol Drug Saf. 2007 Mar;16(3)

View Publication

An observational cohort study investigating the cardiovascular safety of tadalafil when prescribed in primary care in England: mortality due to ischaemic heart disease.

  • Author

    Lorna Hazell Andrew Boshier Scott Harris Lynda V Wilton Saad A W Shakir

    Lorna Hazell, Andrew Boshier, Scott Harris, Lynda Wilton, Saad Shakir

  • Cite

    BJU Int. 2007 Feb;99(2):387-93

View Publication

Thoughts on signal detection in pharmacovigilance

  • Author

    Saad A W Shakir

    Saad Shakir

  • Cite

    Drug Saf. 2007;30(7):603-6

View Publication

A modified prescription-event monitoring study to assess the introduction of Seretide Evohaler in England: an example of studying risk monitoring in pharmacovigilance.

  • Author

    Michael J Perrio Lynda V Wilton Saad A W Shakir

    Michael Perrio, Lynda Wilton, Saad Shakir

  • Cite

    Drug Safety. 2007;30(8):681-95.

View Publication

Safety of zafirlukast: results of a postmarketing surveillance study on 7976 patients in England.

  • Author

    Beverley R Twaites Lynda V Wilton Saad A W Shakir

    Beverley Twaites, Lynda Wilton, Saad Shakir

  • Cite

    Drug Saf. 2007;30(5):419-29

View Publication

Safety profile of rosuvastatin : results of a prescription-event monitoring study of 11 680 patients

  • Author

    Rachna Kasliwal Lynda V Wilton Victoria Cornelius Beate Aurich-Barrera Saad A W Shakir

    Rachna Kasliwal, Lynda Wilton, Victoria Cornelius, Beate Aurich-Barrera, Saad Shakir

  • Cite

    Drug Saf. 2007;30(2):157-70

View Publication

Application of the bradford hill criteria to assess the causality of cisapride-induced arrhythmia: a model for assessing causal association in pharmacovigilance

  • Author

    Michael Perrio Simon Voss Saad A W Shakir

    Michael Perrio, Simon Voss, Saad Shakir

  • Cite

    Drug Saf. 2007;30(4):333-46.

View Publication

Safety profile of orlistat: results of a prescription-event monitoring study

  • Author

    N V Acharya L V Wilton S A W Shakir

    Nayan Acharya, Lynda Wilton, Saad Shakir

  • Cite

    Int J Obes (Lond). 2006 Nov;30(11):1645-52

View Publication

Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes

  • Author

    Josephine Djulus Gideon Koren Thomas R Einarson Lynda Wilton Saad Shakir Orna Diav-Citrin Diane Kennedy Sharon Voyer-Lavigne Marco de Santis Adrienne Einarson

    Josephine Djulus, Gideon Koren, Thomas Einarson, Lynda Wilton, Saad Shakir, Orna Diav-Citrin, Diane Kennedy, Sharon Voyer-Lavigne, Marco de Santis, Adrienne Einarson

  • Cite

    J Clin Psychiatry. 2006 Aug;67(8):1280-4

View Publication

Examination of the safety and use of apomorphine prescribed in general practice in England as a treatment for erectile dysfunction

  • Author

    Karyn M Maclennan Andrew Boshier Lynda V Wilton Saad A W Shakir

    Karyn Mackennan, Andrew Boshier, Lynda Wilton, Saad Shakir

  • Cite

    BJU Int. 2006 Jul;98(1):125-31

View Publication

Safety profile of repaglinide as used in general practice in England: results of a prescription-event monitoring study

  • Author

    V Marshall L Wilton S Shakir

    Vanessa Marshall, Lynda Wilton, Saad Shakir

  • Cite

    Acta Diabetol. 2006 May;43(1):6-13

View Publication

Serious skin reactions and selective COX-2 inhibitors: a case series from prescription-event monitoring in England

  • Author

    Deborah Layton Vanessa Marshall Andrew Boshier Peter Friedmann Saad A W Shakir

    Deborah Layton, Vanessa Marshall, Andrew Boshier, Peter Friedmann, Saad Shakir

  • Cite

    Drug Saf. 2006;29(8):687-96

View Publication